nDatalyze Corp

OTCQB:NDATF USA Health Information Services
Market Cap
$743.89K
Market Cap Rank
#37209 Global
#12113 in USA
Share Price
$0.02
Change (1 day)
+0.00%
52-Week Range
$0.02 - $0.02
All Time High
$0.26
About

nDatalyze Corp. provides technologically based solutions related to applying machine learning to a records database to predict probable mental health conditions. It offers Sigmund, a machine-learning-based online mental health application for the mental health system, such as misdiagnosis and mis prescription. The company was formerly known as MedXtractor Corp. and changed its name to nDatalyze C… Read more

nDatalyze Corp (NDATF) - Net Assets

Latest net assets as of November 2025: $419.75K USD

Based on the latest financial reports, nDatalyze Corp (NDATF) has net assets worth $419.75K USD as of November 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($438.54K) and total liabilities ($18.79K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $419.75K
% of Total Assets 95.72%
Annual Growth Rate 7.43%
5-Year Change -33.07%
10-Year Change N/A
Growth Volatility 75.76

nDatalyze Corp - Net Assets Trend (2018–2025)

This chart illustrates how nDatalyze Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for nDatalyze Corp (2018–2025)

The table below shows the annual net assets of nDatalyze Corp from 2018 to 2025.

Year Net Assets Change
2025-02-28 $536.16K -36.14%
2024-02-29 $839.65K +46.60%
2023-02-28 $572.74K -64.85%
2022-02-28 $1.63 Million +103.39%
2021-02-28 $801.08K +25.77%
2020-02-29 $636.92K +164.24%
2019-02-28 $241.04K -25.76%
2018-02-28 $324.68K --

Equity Component Analysis

This analysis shows how different components contribute to nDatalyze Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 408242900.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (February 2025)

Component Amount Percentage
Other Components $4.64 Million 866.14%
Total Equity $536.16K 100.00%

nDatalyze Corp Competitors by Market Cap

The table below lists competitors of nDatalyze Corp ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in nDatalyze Corp's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 839,646 to 536,163, a change of -303,483 (-36.1%).
  • Net loss of 554,476 reduced equity.
  • New share issuances of 194,993 increased equity.
  • Other comprehensive income decreased equity by 58,108.
  • Other factors increased equity by 114,108.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income $-554.48K -103.42%
Share Issuances $194.99K +36.37%
Other Comprehensive Income $-58.11K -10.84%
Other Changes $114.11K +21.28%
Total Change $- -36.14%

Book Value vs Market Value Analysis

This analysis compares nDatalyze Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.39x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has increased from 0.70x to 1.39x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2018-02-28 $0.03 $0.02 x
2019-02-28 $0.01 $0.02 x
2020-02-29 $0.02 $0.02 x
2021-02-28 $0.03 $0.02 x
2022-02-28 $0.04 $0.02 x
2023-02-28 $0.01 $0.02 x
2024-02-29 $0.02 $0.02 x
2025-02-28 $0.01 $0.02 x

Capital Efficiency Dashboard

This dashboard shows how efficiently nDatalyze Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -103.42%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -32349.82%
  • • Asset Turnover: 0.00x
  • • Equity Multiplier: 1.05x
  • Recent ROE (-103.42%) is below the historical average (-87.78%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2018 -93.58% 0.00% 0.00x 1.01x $-336.31K
2019 -106.61% -158.24% 0.60x 1.12x $-281.07K
2020 -5.75% -6.89% 0.79x 1.06x $-100.29K
2021 -87.20% -105.40% 0.76x 1.09x $-778.63K
2022 -72.02% -276.16% 0.25x 1.05x $-1.34 Million
2023 -215.13% -719.62% 0.20x 1.51x $-1.29 Million
2024 -18.53% -161.51% 0.11x 1.05x $-239.57K
2025 -103.42% -32349.82% 0.00x 1.05x $-608.09K

Industry Comparison

This section compares nDatalyze Corp's net assets metrics with peer companies in the Health Information Services industry.

Industry Context

  • Industry: Health Information Services
  • Average net assets among peers: $79,108,599
  • Average return on equity (ROE) among peers: -247.59%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
nDatalyze Corp (NDATF) $419.75K -93.58% 0.04x $576.33K
Accolade, Inc. (ACCD) $473.79 Million -97.02% 0.91x $448.32 Million
Achiko AG (ACHKF) $-4.58 Million 0.00% 0.00x $314.42K
Ascom Holding AG (ACMLF) $78.70 Million 22.11% 1.51x $152.13 Million
Accelera Innovations Inc (ACNV) $-462.52K 0.00% 0.00x $5.72K
Aclarion Inc (ACON) $-7.08 Million 0.00% 0.00x $1.89 Million
Alternate Health Corp (AHGIF) $1.07 Million -2231.82% 7.94x $6.50K
AI/ML Innovations Inc (AIMLF) $2.09 Million -130.52% 0.72x $6.84 Million
NetraMark Holdings Inc. (AINMF) $-198.56K 0.00% 0.00x $70.13 Million
AMJ Global Technology (AMJT) $-21.78K 0.00% 0.00x $10.99 Million
American Well Corp (AMWL) $247.79 Million -38.62% 0.31x $78.62 Million